Unknown PHASE4 INTERVENTIONAL 2-arm NCT00920101

Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging

Effect of Atorvastatin on Inflammatory Atherosclerotic Plaques Assessed by FDG-PET Imaging

Sponsor: National Defense Medical College, Japan

Interventions Atorvastatin Lifestyle counseling

Updated 5 times since 2017 Last updated: Mar 11, 2013 Started: Jun 30, 2009 Primary completion: Sep 30, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Atherosclerosis and Inflammation, this trial is ongoing. The trial is conducted by National Defense Medical College, Japan and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Defense Medical College, Japan

Data source: National Defense Medical College, Japan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tokotozawa, Japan